Where does Cemm—forschungszentrum Für Molekulare Medizin Gmbh rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Cemm—forschungszentrum Für Molekulare Medizin Gmbh ranks #25,973 of 50,000 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

What is Cemm—forschungszentrum Für Molekulare Medizin Gmbh's Innovation Score?

Cemm—forschungszentrum Für Molekulare Medizin Gmbh has an Innovation Score of 37.8 out of 100 (top 43% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Cemm—forschungszentrum Für Molekulare Medizin Gmbh's patent grant rate increasing or decreasing?

Cemm—forschungszentrum Für Molekulare Medizin Gmbh's recent grant velocity is +50% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Cemm—forschungszentrum Für Molekulare Medizin Gmbh's patents?

Cemm—forschungszentrum Für Molekulare Medizin Gmbh's patents average 21.3 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Cemm—forschungszentrum Für Molekulare Medizin Gmbh

Q: How many patents does Cemm—forschungszentrum Für Molekulare Medizin Gmbh hold?

Cemm—forschungszentrum Für Molekulare Medizin Gmbh holds 10 US utility patents granted between 2016 and 2022, spanning 11 technology areas.

Q: What technology areas does Cemm—forschungszentrum Für Molekulare Medizin Gmbh focus on?

Cemm—forschungszentrum Für Molekulare Medizin Gmbh's top technology area is A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS) with 7 patents. Grants appear in 11 CPC subclasses total.

Q: How is the Cemm—forschungszentrum Für Molekulare Medizin Gmbh patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO PatentsView assignee record - 10 granted patents across 11 technology areas, recorded in grant years 2016–2022. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS).

Compiled by PlainPatent · May 15, 2026

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Cemm—forschungszentrum ranks #25,973 of 50,000 tracked US assignees by granted-patent volume, with 10 patents across 11 technology areas.

#25,973
of 50,000 US assignees by volume: Top 43%
by Innovation Score (37.8/100): 21.3
avg claims per patent: +50%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R25973 · Foreign Corporation #25,973 · 10 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-DENSE · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 10 grants
MID-PACK #25,973/50,000
PHOTO-FINISH Carr Lane Manufactur…
CPC-FOCUS A61P · 11 areas
INNOV-THIN 37.8/100
CLAIMS-DENSE 21.3 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-SURGE +50% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Carr Lane Manufacturing Company (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Cemm—forschungszentr… · this assignee

38
3D Lighting Innovati… · lowest

7

What this shows Cemm—forschungszentrum's Innovation Score is 37.8/100 (top 43% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Cemm—forschungszentrum's grants concentrate

Cemm—forschungszentrum Für Molekulare Medizin Gmbh is a focused PatentsView assignee: 11 CPC subclasses with 70% of grants classified under A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS). Peak complete grant year is 2022 (3 grants) versus a trough of 1 in 2018. By volume, Cemm—forschungszentrum sits between Carr Lane Manufacturing Company and Cerebral Assessment Systems, Llc.

Cemm—forschungszentrum's three-year grant acceleration

Cemm—forschungszentrum Für Molekulare Medizin Gmbh shows 3 grants in 2022–2024 against only 4 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Carr Lane Manufac…

10
Carsem (M) SDN BHD

10
Casabella Holding…

10
Cave Consulting G…

10
Cellucomp

10
Center Rock

10
Centro De Investi…

10
Cerebral Assessme…

10
Cemm—Forschungsze… ◀

10

What this shows Cemm—forschungszentrum holds 10 patents at rank #26,022, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Cemm—forschungszentrum

By rank, the assignees closest to #26,022 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Cemm—forschungszentrum's primary technology class.

Cemm—forschungszentrum's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

38 Top 43% higher than 57% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2022

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Cemm—forschungszentrum Für Molekulare Medizin Gmbh patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	2	20.0%
2018	1	10.0%
2019	1	10.0%
2020	2	20.0%
2021	1	10.0%
2022	3	30.0%

Which technologies does Cemm—forschungszentrum Für Molekulare Medizin Gmbh patent most?

A61P - SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 7

A61K - PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES 7

G01N - INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 7

C12Q - MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS ; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES 4

C07K - PEPTIDES 4

C12N - MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA 4

C12M - APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS 2

Y02A - TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE 1

C40B - COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES 1

C07D - HETEROCYCLIC COMPOUNDS 1

B01L - CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE 1

Top 11 of 11 technology areas

Where it ranks

Overall rank by patents

#25,973

of 50,000 tracked assignees

Innovation Score

37.8 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.